Safety, Tolerability and Pharmacokinetics Study of Subcutaneous Doses of Turoctocog Alfa Pegol


Clinical Trial

Offered by: Nemours
Location: Orlando, Fla.

Trial Name

Safety, Tolerability and Pharmacokinetics Study of Single and Multiple Subcutaneous Doses of Turoctocog Alfa Pegol in Patients With Hemophilia A.

What is the trial about?

The purpose of this study is to find out how well the study drug works when injected under the skin.

Who can participate?

18–24 years old men with a diagnosis of hemophilia A.

What is involved?

Ten visits to Nemours Children’s Hospital over two months. Procedures and tests to be done include physical exam, ECG, blood and urine samples and questions about your medical history.

Contact Nemours Clinical Trials

Trial Name: Safety, Tolerability and Pharmacokinetics Study of Single and Multiple Subcutaneous Doses of Turoctocog Alfa Pegol in Patients With Hemophilia A.

Contact Information

(800) 354-5690
ClinicalTrials@nemours.org